Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

ROCIO PESTANA

Allopathic & Osteopathic Physicians Internal Medicine

NPI
1316068612
CMS profile
150668
Location
SOUTH MIAMI, FL

General Payments · PY2018–2024

$6,079.22

  • Reported across 299 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$979.43

36 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $979.43 36

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Acerta Pharma LLC $291.99 9
ABBVIE INC. $209.36 6
Novo Nordisk AS $101.60 5
Boehringer Ingelheim Pharmaceuticals, Inc. $95.74 3
Exact Sciences Corporation $88.30 3
GlaxoSmithKline, LLC. $73.46 3
Lilly USA, LLC $61.33 4
PFIZER INC. $36.36 2
IBSA Pharma Inc. $21.29 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $1,104.25 54
PY2019 $794.00 44
PY2020 $825.45 48
PY2021 $873.76 51
PY2022 $748.72 36
PY2023 $753.61 30
PY2024 $979.43 36

Payment records · PY2024 (36)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $28.19 01/26/2024 Food and Beverage Undisputed 01/23/2026 1105246093 CMS
ABBVIE INC. $124.56 02/01/2024 Food and Beverage Undisputed 01/23/2026 1105246098 CMS
ABBVIE INC. $4.75 03/08/2024 Food and Beverage Undisputed 01/23/2026 1105246102 CMS
ABBVIE INC. $26.67 05/01/2024 Food and Beverage Undisputed 01/23/2026 1105246106 CMS
ABBVIE INC. $3.17 09/20/2024 Food and Beverage Undisputed 01/23/2026 1105246110 CMS
ABBVIE INC. $22.02 10/18/2024 Food and Beverage Undisputed 01/23/2026 1105246114 CMS
AstraZeneca Pharmaceuticals LP $23.27 01/22/2024 Food and Beverage Undisputed 01/23/2026 1104420707 CMS
AstraZeneca Pharmaceuticals LP $27.74 03/11/2024 Food and Beverage Undisputed 01/23/2026 1104274113 CMS
AstraZeneca Pharmaceuticals LP $18.55 04/08/2024 Food and Beverage Undisputed 01/23/2026 1104262001 CMS
AstraZeneca Pharmaceuticals LP $19.13 05/20/2024 Food and Beverage Undisputed 01/23/2026 1105798542 CMS
AstraZeneca Pharmaceuticals LP $18.49 06/24/2024 Food and Beverage Undisputed 01/23/2026 1104412559 CMS
AstraZeneca Pharmaceuticals LP $27.06 07/29/2024 Food and Beverage Undisputed 01/23/2026 1104200073 CMS
AstraZeneca Pharmaceuticals LP $23.74 08/19/2024 Food and Beverage Undisputed 01/23/2026 1104457926 CMS
AstraZeneca Pharmaceuticals LP $17.01 10/21/2024 Food and Beverage Undisputed 01/23/2026 1105530656 CMS
AstraZeneca Pharmaceuticals LP $117.00 11/21/2024 Food and Beverage Undisputed 01/23/2026 1105202730 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $31.39 06/17/2024 Food and Beverage Undisputed 01/23/2026 1117958892 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $34.78 08/26/2024 Food and Beverage Undisputed 01/23/2026 1117958894 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $29.57 12/02/2024 Food and Beverage Undisputed 01/23/2026 1117958890 CMS
Exact Sciences Corporation $31.02 05/14/2024 Food and Beverage Undisputed 01/23/2026 1114832890 CMS
Exact Sciences Corporation $35.46 07/01/2024 Food and Beverage Undisputed 01/23/2026 1114832896 CMS
Exact Sciences Corporation $21.82 10/07/2024 Food and Beverage Undisputed 01/23/2026 1114832902 CMS
GlaxoSmithKline, LLC. $26.57 02/10/2024 Food and Beverage Undisputed 01/23/2026 1116702167 CMS
GlaxoSmithKline, LLC. $26.57 04/05/2024 Food and Beverage Undisputed 01/23/2026 1115853083 CMS
GlaxoSmithKline, LLC. $20.32 06/11/2024 Food and Beverage Undisputed 01/23/2026 1115857359 CMS
IBSA Pharma Inc. $21.29 03/18/2024 Food and Beverage Undisputed 01/23/2026 1142985302 CMS
Lilly USA, LLC $18.02 01/05/2024 Food and Beverage Undisputed 01/23/2026 1135398853 CMS
Lilly USA, LLC $14.34 06/11/2024 Food and Beverage Undisputed 01/23/2026 1135337998 CMS
Lilly USA, LLC $13.16 09/10/2024 Food and Beverage Undisputed 01/23/2026 1135357364 CMS
Lilly USA, LLC $15.81 10/10/2024 Food and Beverage Undisputed 01/23/2026 1135337993 CMS
Novo Nordisk Inc $15.43 01/12/2024 Food and Beverage Undisputed 01/23/2026 1097684188 CMS
Novo Nordisk Inc $24.88 02/05/2024 Food and Beverage Undisputed 01/23/2026 1096871640 CMS
Novo Nordisk Inc $18.84 06/03/2024 Food and Beverage Undisputed 01/23/2026 1096628919 CMS
Novo Nordisk Inc $19.98 09/06/2024 Food and Beverage Undisputed 01/23/2026 1097685400 CMS
Novo Nordisk Inc $22.47 12/16/2024 Food and Beverage Undisputed 01/23/2026 1096890364 CMS
PFIZER INC. $17.77 09/16/2024 Food and Beverage Undisputed 01/23/2026 1131978275 CMS
PFIZER INC. $18.59 10/14/2024 Food and Beverage Undisputed 01/23/2026 1132029091 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.